Tumour Microenvironment in Therapy of Metastatic Cancer
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 2
Abstract
GLOBOCAN 2020 has reported that the global cancer burden is 19.3 million cases, with 10 million deaths[1]. The overall survival (OS) after treatment with innovative cancer therapies has not changed for most metastatic cancer patients, and more in-depth study is needed. Several studies have suggested that understanding the cellular and molecular mechanisms underlying metastatic processes can be used as a novel strategy to disrupt cancer cell pathways and contribute to the development of effective and safe therapies against metastatic cancer. Recent studies have shown that the tumour microenvironment (TME) is responsible for reprogramming tumour initiation, progression, invasion, and metastasis. Thus, TME probably hinders positive responses to innovative therapies. Therefore, clinicians must consider targeting major cell components associated with TME instead of only using presently available genomic profiles of tumours for effective treatment of metastatic cancer patients. Various investigators have already identified specific cell types from TME that are involved in the progression and resistance of cancer cells[2]. These include circulating tumour cells (CTCs), cancer-associated fibroblasts (CAFs), cancer stem cells (CSCs), immune cells, endothelial cells, etc., from highly metastatic cancer patients. The development of this support niche is critical for persistent uncontrolled growth of cancer at the metastatic stage. This special issue on “Tumour Microenvironment in Therapy of Metastatic Cancer” describes various cell types and components involved in tumour growth, invasion and metastasis, and also addresses various strategies that can be implemented to target these resistant cancer cells for effective cure of metastatic cancer in the near future.
Authors and Affiliations
Pravin D. Potdar
Keywords
Related Articles
- EP ID EP740188
- DOI 10.54457/DR.202302008
- Views 27
- Downloads 1
Utilization of Traditional Chinese Medicine Monomers in the Therapeutic Management of Enteritis-Associated Inflammation
Chronic enteritis with inflammatory characteristics is a persistent and recurring inflammation of the intestinal tract, resulting from a myriad of causative factors. Currently, the customary pharmacological treatments fo...
The Clinical Feature of Chronic Hepatitis B Patients with High HBV pgRNA
ackground and Aims At present, nucleos(t)ide analogue (NA) is usually used to treat chronic hepatitis B, but there are still some patients with high levels of pgRNA after long-term treatment. We tried to study the clinic...
Tumour Microenvironment in Therapy of Metastatic Cancer
GLOBOCAN 2020 has reported that the global cancer burden is 19.3 million cases, with 10 million deaths[1]. The overall survival (OS) after treatment with innovative cancer therapies has not changed for most metastatic ca...
An Analysis of Gut Bacterial and Fungal Community Interactions in Saxifraga stolonifera Curt.-Treated Mice
Backgrounds Saxifraga stoloniferaCurt. is valued for its great medicinal potentials, especially for anti-inflammatory activity. The gut microbiome is gradually regarded as a pivotal part that contributes to the therapeut...
Characteristics of Patients with Cryptogenic Cirrhosis: A Retrospective Study
Backgrounds This study aimed to achieve a better understanding of the characteristics of patients with cryptogenic cirrhosis (CC). Methods We retrospectively enrolled 50 patients with CC between January 2018 and Decembe...